Natura & Co Holding SA
BOVESPA:NTCO3
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Natura & Co Holding SA
BOVESPA:NTCO3
|
BR |
|
F
|
Fresenius Medical Care AG & Co KGaA
XETRA:FME
|
DE |
|
Li-Cycle Holdings Corp
NYSE:LICY
|
CA |
|
C
|
CEL-SCI Corp
AMEX:CVM
|
US |
Wall St Price Targets
NTCO3 Price Targets Summary
Natura & Co Holding SA
According to Wall Street analysts, the average 1-year price target for NTCO3 is 12.15 BRL with a low forecast of 9.8 BRL and a high forecast of 14.7 BRL.
Price Targets
Our estimates are sourced from the pool of sell-side and buy-side analysts that we have access to. What you see on other sites is mostly sourced from sell-side analysts.
What is NTCO3's stock price target?
Price Target
12.15
BRL
According to Wall Street analysts, the average 1-year price target for NTCO3 is 12.15 BRL with a low forecast of 9.8 BRL and a high forecast of 14.7 BRL.
What is the Revenue forecast for Natura & Co Holding SA?
Projected CAGR
2%
Over the last 9 years, the compound annual growth rate for Revenue has been 13%. The projected CAGR for the next 4 years is 2%.
What is the Operating Income forecast for Natura & Co Holding SA?
Projected CAGR
43%
Over the last 9 years, the compound annual growth rate for Operating Income has been -6%. The projected CAGR for the next 4 years is 43%.
